Palvella Therapeutics PVLA Book value per share

Book value per share at other companies

Viridian Therapeutics, Inc.VRDN

$6.31-23.8%

ANI PharmaceuticalsANIP

$27.25+26.7%

Arcutis Biotherapeutics, Inc.ARQT

$1.62+48.3%

Zevra Therapeutics, Inc.ZVRA

$3.55+70.5%

Eton Pharmaceuticals, Inc.ETON

$0.97+6.7%

Rigel PharmaceuticalsRIGL

$20.31+1,888%

FAQ

What is Palvella Therapeutics's book value per share?

Palvella Therapeutics (PVLA) reported book value per share of $17.75 in Q1 2026.

How has Palvella Therapeutics's book value per share changed year-over-year?

Palvella Therapeutics's book value per share increased by 251.8% year-over-year, from $5.05 to $17.75.

What is the long-term trend for Palvella Therapeutics's book value per share?

Over 3 years (2020 to 2025), Palvella Therapeutics's book value per share has grown at a 63.5% compound annual growth rate (CAGR), from $0.57 to $2.49.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.